CORONAVIRUS DISEASE (COVID-19) TREATMENT ALGORITHMS IN PATIENTS WITH QT INTERVAL PROLONGATION

Clicks: 112
ID: 106279
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Since the frst cases of coronavirus disease (COVID-19) have been identifed, the search for effective drugs for its treatment has not stopped. The most promising in the treatment of COVID-19 are antimalarial, antiretroviral drugs and macrolide antibiotics. A common side effect for these groups of drugs is their ability to prolong the QT interval and induce paroxysms of polymorphic ventricular tachycardia torsades de pointes, especially in patients with genetic defects of ventricular myocardial repolarization. This article provides management algorithms of COVID-19 in patients with QT interval prolongation and risk of life-threatening ventricular arrhythmias, developed with the support of the EurAsian Arrhythmology Association (EURA-3).
Reference Key
v2020coronavirusurnal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors V., Kalatsei L.;A., Snezhitskiy V.;V., Ardashev A.;
Journal Žurnal grodnenskogo gosudarstvennogo medicinskogo universiteta
Year 2020
DOI
DOI not found
URL
http://journal-grsmu.by/index.php/ojs/article/view/2538
Keywords
Microbiology Medicine (General) Medicine Science (General) Dentistry diseases of the digestive system. gastroenterology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.